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Microglia become activated by multiple types of
damage in the nervous system and play essential
roles in neuronal pathologies. However, how micro-
glia transform into reactive phenotypes is poorly
understood. Here, we identify the transcription factor
interferon regulatory factor 8 (IRF8) as a critical regu-
lator of reactive microglia. Within the spinal cord,
IRF8 expression was normally low; however, the
expression was markedly upregulated in microglia,
but not in neurons or astrocytes, after peripheral
nerve injury (PNI). IRF8 overexpression in cultured
microglia promoted the transcription of genes asso-
ciated with reactive states; conversely, IRF8 defi-
ciency prevented these gene expressions in the
spinal cord following PNI. Furthermore, IRF8-defi-
cient mice were resistant to neuropathic pain, a
common sequela of PNI, and transferring IRF8-over-
expressing microglia spinally to normal mice pro-
duced pain. Therefore, IRF8 may activate a program
of gene expression that transforms microglia into
a reactive phenotype. Our findings provide a newly
observed mechanism for microglial activation.
INTRODUCTION
Microglial cells are the resident immune-related glial cells of the
central nervous system (CNS) that are crucial for maintaining
homeostasis and sensing pathological alterations in the nervous
system, such as following infection and injury (Glass et al., 2010;
Hanisch and Kettenmann, 2007; Perry et al., 2010; Ransohoff
and Cardona, 2010). Under normal conditions, microglia survey
the surrounding local environment by actively moving their
branched processes. As a consequence of multiple types of
damage in the nervous system, microglia transform to reactive
states through a progressive series of cellular and molecular334 Cell Reports 1, 334–340, April 19, 2012 ª2012 The Authorschanges, including morphological hypertrophy, proliferation
and expression of various genes. In particular, expression of
cell-surface receptors (e.g., toll-like receptors [TLRs] and nucle-
otide receptors [P2X and P2Y receptors]) and proinflammatory
cytokines (e.g., interleukin [IL]-1b) is a critical process for
inducing reactive phenotypes of microglia linked to the patho-
genesis of various CNS diseases such as multiple sclerosis, Alz-
heimer’s disease, and neuropathic pain (Glass et al., 2010; Inoue
and Tsuda, 2009; McMahon and Malcangio, 2009; Perry et al.,
2010). However, the molecular mechanisms by which microglia
switch to reactive phenotypes are poorly understood.
RESULTS AND DISCUSSION
As microglia can transform into reactive phenotypes through the
activation of gene transcription, we considered that reactive
states of microglia may be controlled by transcription factors.
To investigate this possibility, we performed a genome-wide
screen of mRNAs from the spinal cord of mice with or without
peripheral nerve injury (PNI), a model of CNS pathology in which
remote injury of a peripheral nerve (fourth lumbar [L4] spinal
nerve) results in activation of microglia in the spinal dorsal horn
where the injured nerve projects. In three independent DNA
microarray analyses, we identified interferon regulatory factor 8
(IRF8) as a transcription factor whose expression was sig-
nificantly upregulated in the spinal cord after PNI (p = 0.015,
Figure S1A). IRF8 is a member of the IRF family (IRF1-9), and is
expressed in immune cells such as lymphocytes and dendritic
cells. In the periphery, IRF8 plays pivotal roles in the immune
system (Honda and Taniguchi, 2006; Tamura et al., 2000,
2008), but its role in the CNS is entirely unknown. Thus, we deter-
mined the type of cells expressing IRF8 in the spinal cord after
PNI using an immunofluorescence approach. Three days after
PNI, on sections from the L4 spinal dorsal horn, we observed
strong immunofluorescence of IRF8 protein dotted on the ipsilat-
eral side (Figure 1A). In contrast, on the contralateral side where
intact nerves project, IRF8 immunofluorescence was weak. The
observed staining was not a nonspecific signal because no IRF8
immunofluorescence was detected in mice lacking IRF8 (Irf8–/–)
Figure 1. PNI Induces IRF8 Upregulation Exclusively in Microglia in the Spinal Cord
(A) Visualization of IRF8 protein in the dorsal spinal cord 3 days after PNI.
(B) Nuclear localization of IRF8.
(C–H) Double immunolabeling of IRF8 with Iba1 (C), OX-42 (D), GFAP (E), NeuN (F), MAP2 (G), and NF200 (H).
(I) Real-time PCR analysis of Irf8 mRNA in WT mouse spinal cord before (Naive) and after PNI. Values represent the relative ratio of Irf8 mRNA (normalized to
Gapdh mRNA) to the contralateral side of naive mice (n = 6; **p < 0.01).
(J) Western blot analysis of IRF8 protein in the spinal cords of WT mice before (Naive) and after PNI.
(K) A histogram of the relative band density ratio of IRF8 (normalized to b-actin) to the contralateral side of naive mice at each time point (n = 5; **p < 0.01).
Values are means ± SEM for all groups.
Scale bars: 100 mm (A), 10 mm (B), 50 mm (C–H).
See also Figure S1.(Figure S1B). At higher magnification, almost all IRF8 immunoflu-
orescence colocalized with the nuclear marker DAPI (Figure 1B).
We further performed double-immunolabeling with cell type-
specific markers and found that almost all IRF8+ cells were
positive for themicroglial markers Iba1 (328/332 IRF8+ cells; Fig-
ure 1C) and OX-42 (363/368 IRF8+ cells; Figure 1D). IRF8+ cells
were not double-labeled with markers for neurons (NeuN,
MAP2, and NF200) or astrocytes (GFAP) (Figures 1E–1H). By
triple labeling with IRF8/Iba1/DAPI, we confirmed the nuclear
localization of IRF8 in microglia (Figure S1C). Spinal microglia
with the high levels of IRF8 showed activated morphology (Fig-
ure 1C), and the intensity of IRF8 immunofluorescence perIba1+ cell was markedly increased (Figures S1E and S1F). We
therefore concluded that, in the dorsal horn following PNI, reac-
tive microglia are the cell type which express IRF8 and that the
level of IRF8 expression is dramatically increased in individual
reactive microglia. In addition, microglia-specific IRF8 upregula-
tion in the spinal cord was also induced in rats after PNI (Figures
S1K–S1O). Furthermore, we examined the temporal pattern of
IRF8 expression by real-time RT-PCR analysis and found that
Irf8 mRNA levels, which were low in naive mice, were increased
in the spinal cord ipsilateral to PNI, starting from postoperative
day 1 and peaking on day 3 and persisting for more than 3 weeks
(Figure 1I; Figure S1D). Correspondingly, western blot analysisCell Reports 1, 334–340, April 19, 2012 ª2012 The Authors 335
Figure 2. Forced Expression of IRF8 in Microglia
Promotes Gene Transcription
Real-time PCR analysis of the mRNA of genes of interest
in cultured microglia 72 hr after transduction. Values
represent the relative ratio of mRNA (of tested genes,
normalized to Gapdh mRNA) to control microglia with
GFP alone (n = 5–7, *p < 0.05, ***p < 0.001 versus GFP;
#p < 0.05, ##p < 0.01, ###p < 0.001 versus IRF8-GFP).
Values are the mean ± SEM for all groups.
See also Figure S2.demonstrated upregulation of IRF8 protein in the ipsilateral
spinal cord after PNI (Figures 1J and 1K). Spinal IRF8 upregula-
tion at both earlier (24–44 hr) and later (days 7–21) time points
after PNI was also specific to microglia (Figures S1G–S1J), indi-
cating that the microglia-specific upregulation of IRF8 persists
for at least 3 weeks after PNI.
To determine if IRF8 activates transcription in microglia, we
transduced primary cultured microglia with a lentiviral vector
encoding IRF8 tagged with green fluorescent protein (GFP)
(IRF8–GFP) or a control vector encoding GFP alone, and exam-
ined the levels of gene transcripts in microglia. On the basis of
current concepts that there aremultiple activity states of reactive
microglia (Hanisch and Kettenmann, 2007; Perry et al., 2010;
Ransohoff and Cardona, 2010), we focused on genes involved
in microglial innate responses (TLR2 [Tlr2] and TLR4 [Tlr4])
(Rivest, 2009), chemotaxis (the metabotropic nucleotide re-
ceptor P2Y12R [P2ry12] and the chemokine receptor CX3CR1
[Cx3cr1]) (Haynes et al., 2006; Honda et al., 2001; Tran and
Miller, 2003) and inflammatory components (IL-1b [Il1b], IL-6
[Il6], cathepsin S [Ctss], brain-derived neurotrophic factor
[Bdnf], the ionotropic nucleotide receptors P2X4R [P2rx4], and
P2X7R [P2rx7]) (Burnstock, 2008; Clark et al., 2007; Coull
et al., 2005; Inoue and Tsuda, 2009; Tsuda et al., 2003). First,
we confirmed transduction efficacy of the two vectors (Figures
S2A and S2B) and the Irf8 mRNA level in microglia with IRF8–
GFP (Figure S2C). In IRF8-transduced microglia, the mRNA
levels for Tlr2, P2ry12, Cx3cr1, Il1b, Ctss, and P2rx4 were
increased (Figure 2). We confirmed similar effects of IRF8 using
the microglial cell line BV2 (Figures S2D and S2E). Bdnf mRNA336 Cell Reports 1, 334–340, April 19, 2012 ª2012 The Authorstended to be increased (Figure 2), and mRNAs
for Tlr4, Il6, and P2rx7 were not altered by
IRF8 overexpression (Figure 2). Furthermore, in
microglia transduced with a mutant IRF8 in
which lysine at amino acid position 79 (required
for DNA-binding activity; Tamura et al., 2000)
was replaced with Glu (IRF8[K79E]), expression
of genes that were induced by wild-type IRF8
was not increased (Figure 2). The failure of the
mutant protein to induce gene expression was
not due to insufficient levels of mutant IRF8
(Figure S2C). Thus, forced IRF8 expression acti-
vates transcription of genes associated with
a reactive state of microglia in a manner that
depends on its ability to bind DNA.
To investigate the role of IRF8 in microglial
gene expression in vivo, we subjected Irf8–/–mice and their wild-type (WT) littermates to PNI and examined
the abundance of microglial gene transcripts in the spinal cord.
Based on our findings in vitro (Figure 2), we focused on putative
IRF8-regulated microglial genes. In WT mice, the transcript
levels of Tlr2, P2ry12, Cx3cr1, Il1b, Ctss, and P2rx4 were sig-
nificantly increased 7 days after PNI (Figure 3A). However, in
Irf8–/– mice, the PNI-induced increase in expression of Tlr2,
P2ry12, Cx3cr1, Ctss, and Bdnf was suppressed, and P2rx4
and Il1b mRNAs did not significantly increase after PNI (Fig-
ure 3A). These results indicate that IRF8 is necessary for PNI-
induced expression of a set of genes in reactive microglia in vivo.
In addition, we examined gene expression at a later time point.
On day 21 post-PNI, we found, inWTmice, a significant increase
for the genes Tlr2, Cx3cr1, and Ctss in addition to Iba1 (Aif1)
(Figures S3D and S3E). However, like Irf8mRNA on day 21 (Fig-
ure S1D), their levels were lower than those on day 7. Among
them, the upregulation of Ctss and Aif1mRNAs was significantly
suppressed in Irf8–/– mice (Figure S3D). The lesser effects of IRF8
deficiency on microglial gene expression might be related to the
lower level of IRF8 in microglia on day 21 post-PNI.
Robust proliferation of spinal microglia is an early event
occurring after PNI and is an important process for transforming
into a reactive state (Tsuda et al., 2009). Thus, it is possible that
the impaired microglial gene expression in Irf8–/– mice may be
due to a change in this early process. However, PNI-induced
increases in the number of proliferating spinal microglia that
were positive for the proliferation markers Ki-67 and phosphory-
lated-histone H3 (p-HisH3) were indistinguishable between
WT and Irf8–/– mice (Figure 3B). Furthermore, increased
Figure 3. IRF8 Is Required for Microglial Gene Expression, but Not for Microglial Proliferation, in the Spinal Cord after PNI
(A) Real-time PCR analysis of mRNAs of microglial genes in the spinal cords of WT and Irf8–/– mice 7 days after PNI. Values represent the relative ratio of mRNA
(of tested genes, normalized to Gapdh mRNA) to the contralateral side of WT mice. C, contralateral; I, ipsilateral. (n = 6–7, *p < 0.05, **p < 0.01, ***p < 0.001).
(B) Double immunofluorescence for Ki-67 or p-HisH3 (green) and OX-42 (red) in the ipsilateral dorsal horn of WT or Irf8–/– mice 2 days after PNI. A histogram of the
numbers of Ki-67+OX-42+ or p-HisH3+OX-42+ cells in the ipsilateral (I) and contralateral (C) dorsal horn (n = 3, ***p < 0.001).
(C) OX-42 (red) and Iba1 (green) immunofluorescence in the spinal cord of WT and Irf8–/– mice 14 days after PNI.
Values are the mean ± SEM for all groups. Scale bars: 50 mm (B), 200 mm (C), 50 mm (C, insets).
See also Figure S3.immunofluorescence of the microglial marker OX-42 after PNI,
due to a cellular alteration of microglia, was similarly observed
in the ipsilateral dorsal horn of both genotypes after PNI (Fig-
ure 3C). These data indicate that lack of IRF8 does not result
in a global defect in reactive processes of microglia. However,
Irf8–/– mice, surprisingly, showed a marked reduction in Iba1
immunofluorescence on both sides of the spinal cord (Figure 3C),
which was also verified by real-time RT-PCR (Figures S3A and
S3D) and Western blotting (Figure S3B). By using Irf8+/– mice,
we showed that the reduction was dependent on levels of the
Irf8 gene (Figure S3C). The low level of Aif1 mRNA was also
observed in cultured Irf8–/– microglia (Figure S3F) and, con-
versely, was increased in cultured microglia transduced with
IRF8, but not with IRF8(K79E) (Figures S3G and S3H). As there
are IRF elements in the promoter region of the Iba1 gene (Sibinga
et al., 2002), IRF8 may directly control Iba1 expression in
microglia.
Our results above show that IRF8 is crucial for activating gene
expression in reactive microglia in the spinal dorsal horn after
PNI, raising the possibility that IRF8 might contribute to neuronal
pathologies following PNI. Injury to the nervous system arising
from bone compression in cancer, diabetes, infection, autoim-
mune disease or physical injury is known to result in debilitating
chronic pain states (referred to as neuropathic pain) (McMahon
and Malcangio, 2009; Tsuda et al., 2005). A cardinal symptomof neuropathic pain is characterized by tactile allodynia,
abnormal pain hypersensitivity evoked by innocuous stimuli.
Therefore, we investigated whether IRF8 induced in spinal
microglia after PNI contributes to neuropathic allodynia using
Irf8–/– mice. In WT mice, PNI produced a profound, long-term
decrease in pawwithdrawal threshold (PWT) tomechanical stim-
ulation of the hindpaw (Figure 4A). The decrease in PWT on day 1
was comparable between WT and Irf8–/– mice, but Irf8–/– mice
failed to show a further decrease in PWT after 3 days, lasting until
the final time point tested. Irf8–/– mice showed no change in basal
mechanical sensitivity or contralateral PWT after PNI (Figure 4A),
nor did it affect motor function (data not shown). Furthermore,
suppressing upregulated expression of spinal IRF8 after PNI by
intrathecal administration of a small interfering RNA (siRNA)
targeting IRF8, given on day 5 and 6 post-PNI to WT mice that
had developed allodynia, caused a significant recovery in PWT
(Figure 4B). Another IRF8 siRNA also produced similar effects
(Figure S4F). Together, these data indicate that IRF8 upregula-
tion in the spinal cord is necessary for full development and
maintenance of tactile allodynia after PNI.
To further investigate the impact of microglial IRF8 in modu-
lating pain, we employed a model in which cultured microglial
cells are transferred spinally to normal mice (Figure 4C) (Coull
et al., 2005; Tsuda et al., 2003, 2009). Transferring microglia
transduced with GFP alone did not produce any change inCell Reports 1, 334–340, April 19, 2012 ª2012 The Authors 337
Figure 4. Microglial IRF8 Is Necessary for Abnormal Pain Hypersensitivity Caused by PNI
(A) PWT of Irf8–/– andWTmice before (Pre) and after PNI (n = 4; *p < 0.05, **p < 0.01 versus Pre; #p < 0.05, ##p < 0.01, ###p < 0.001 versus the ipsilateral side of WT
mice). C, contralateral; I, ipsilateral.
(B) Reversal of PNI-induced allodynia by intrathecal administration of IRF8 siRNA (20 pmol) once a day for 2 days (on 5 and 6 days post-PNI) in WTmice (n = 3–6,
*p < 0.05). Upper, representative immunoblots of IRF8 and b-actin proteins in the spinal cords of mice treated with control and IRF8 siRNAs on day 7 post-PNI.
(C) Experimental protocol.
(D) PWT of WT mice intrathecally administered with cultured microglia overexpressing either GFP, IRF8–GFP or IRF8(K79E)–GFP (n = 5–6, **p < 0.01 versus Pre;
#p < 0.05 versus WT mice with GFP microglia; xp < 0.05, xxp < 0.01 versus WT mice with IRF8–GFP microglia).
(E) Allodynia by IRF8-transduced cultured microglia was prevented by preincubating microglia with a cocktail of IL-1b neutralizing antibody (5 mg) and
CatS inhibitor (5 pmol) for 15 min before the intrathecal injection of microglia (n = 6–7, *p < 0.05, **p < 0.01 versus Pre; #p < 0.05, ###p < 0.001 versus IRF8–GFP/
control group).
(F) PWT of WT and Irf8–/– mice before (Pre) and after intraplantar CFA injection (n = 5, **p < 0.01 versus Pre).
(G) Hot-plate test. Values represent the latency (s) for animals to lick their hindpaws or jump (n = 6).
(H) Tail-flick test. Values represent the latency (s) to flick their tail from the heat source (n = 4).
(I–K) Capsaicin (I) and formalin (J and K) test. Values are the duration (s) of nociceptive behaviors (I: n = 6, J: n = 8) (**p < 0.01 versusWTmice). (K) Total duration (s)
of nociceptive behaviors for 0–5 min (first phase) and for 10–60 min (second phase).
Values are the mean ± SEM for all groups.
See also Figure S4.PWT (Figure 4D). By contrast, spinal transfer of IRF8-transduced
microglia to normal mice produced a significant decrease in
PWT (Figure 4D). However, IRF8(K79E)-transduced microglia
failed to decrease PWT (Figure 4D). It is possible that transferring
IRF8-transduced microglia may activate endogenous spinal
IRF8 in recipient mice, leading to allodynia. However, IRF8-
transduced microglia also produced behavioral allodynia in
Irf8–/– mice (n = 3, pre: 1.50 ± 0.25 g; 5 hr: 0.58 ± 0.04 g). Thus,
microglial IRF8 is sufficient to produce tactile allodynia, the
behavioral outcome depends on the DNA-binding activity of
IRF8. Microglia-mediated inflammatory components are impli-
cated in enhancing neuronal excitability in the CNS including
the dorsal horn (Inoue and Tsuda, 2009; Kawasaki et al., 2008;
McMahon and Malcangio, 2009). Because gene transcripts up-
regulated by IRF8 included IL1b and Ctss (Figure 2), we tested
the effect of these two inflammatory molecules in behavioral
allodynia elicited by IRF8-expressing microglia. We found that
pretreating IRF8-transduced microglia with a cocktail containing338 Cell Reports 1, 334–340, April 19, 2012 ª2012 The Authorsa function-blocking antibody for IL-1b and an inhibitor of Ctss
attenuated the decrease in PWT by IRF8-transduced microglia
(Figure 4E). Thus, these results imply that inflammatory signals
derived frommicroglia overexpressing IRF8 can produce behav-
ioral allodynia.
Because Irf8–/– mice may have congenital defects in pain
processing, we also tested behavioral responses in other pain
assays. Intraplantar injection of complete Freund’s adjuvant
(CFA), a model of pain caused by local inflammation of the hind-
paw, produced no detectable change in spinal IRF8 expression
(Figure S4G) and caused pain hypersensitivity in both WT and
Irf8–/– mice (Figure 4F). In acute pain assays, behavioral re-
sponses to heat and capsaicin were indistinguishable between
the two genotypes (Figures 4G–4I). Likewise, pain responses
related to tissue damage by injecting dilute formalin into the
hindpaw did not differ, although Irf8–/– mice showed a delay in
onset of the second phase (Figures 4J and 4K). By using several
markers for DRG neurons, we confirmed that the phenotypes of
DRG neurons are comparable between the two genotypes
(Figures S4A–S4E). Thus, microglial IRF8 critically contributes
to chronic pain, especially neuropathic pain, without causing
substantial alterations in basal sensory thresholds, local tissue
inflammation-induced pain or motor performance.
Here, we demonstrate a role for IRF8 in the CNS as a key
transcription regulator of microglia involved in converting to
a reactive state after PNI in vivo. To our knowledge, IRF8 is the
first transcription factor specific to microglia, among CNS-resi-
dent cells, that controls their reactive processes and CNS
pathology. We further found that IRF8 upregulation in brain
microglia was also observed in other models of injury (hypo-
glossal nerve axotomy and kainic acid-induced neuronal injury)
(Figures S1P–S1R), suggesting that upregulation of microglial
IRF8 may be commonly induced following diverse types of
neuronal injury. Interestingly, IRF8 deficiency prevented gene
expressions in microglia without affecting their proliferative
activity. Therefore, our findings suggest that IRF8 is not the
sole transcription factor for microglial activation but rather
activates a program of gene expression that determines
signaling activity of reactive microglia, which provides a newly
observed mechanism for microglial activation. For the IRF8
upregulation in microglia, it has been reported that interferon
(IFN)-g increases IRF8 expression in vitro (Politis et al., 1994)
and IFN-g receptors are expressed in spinal microglia (Tsuda
et al., 2009). However, we found that IFN-g receptor-deficient
mice failed to prevent PNI-induced Irf8 expression in the spinal
cord (Figure S1S), proposing the possible involvement of an
IFN-g-independent mechanism (e.g., TLRs; Barber et al.,
1995). Although elucidating this issue requires further investiga-
tion, our present data suggest that inhibiting upregulated
expression or function of IRF8may provide a way to comprehen-
sively control the expression of a set of genes in reactive micro-
glia. Of importance to therapeutic development, Irf8–/– micewere
resistant to allodynia, and suppressing spinal IRF8 by its siRNA
reversed established allodynia. Although the possible involve-
ment of other cell types expressing IRF8 in neuropathic pain
defects seen in Irf8–/– mice cannot be excluded, our findings
indicate that the development and maintenance of neuropathic
pain requires ongoing activity of microglial IRF8. Therefore, our
results may provide a new therapeutic strategy for neuropathic
pain, for which there is currently no effective therapy. In addition,
reactive microglia with altered expression of various genes by an
as-yet-unknown mechanism play prominent roles in the patho-
genesis of other CNS diseases (Glass et al., 2010; Hanisch and
Kettenmann, 2007; Perry et al., 2010). A recent meta-analysis
identified IRF8 as a susceptibility locus for multiple sclerosis
(De Jager et al., 2009), a refractory neurodegenerative disease
in which reactive microglia are implicated (Glass et al., 2010).
Whether reactive microglia upregulate IRF8 expression and its
transcriptional activity during the course of CNS diseases
remains unknown. However, if so, then this transcription factor
could provide a therapeutic target in disorders of the CNS in
addition to neuropathic pain.EXPERIMENTAL PROCEDURES
Details are further described in the Extended Experimental Procedures.Animals
Male IRF8-deficient mice (Irf8–/–) (Holtschke et al., 1996) and their WT litter-
mates, and C57BL/6 mice were used. All mice used were aged 9–12 weeks
at the start of each experiment and were housed at 22 ± 1C with a 12-hr
light-dark cycle and fed food and water ad libitum. All experimental proce-
dures were performed under the guidelines of Kyushu University.
Peripheral Nerve Injury
Under isoflurane (2%) anesthesia, a unilateral L4 spinal nerve of mice was cut
as described previously (Tsuda et al., 2009).
Microarray Analysis
Total RNA from the L3–L5 spinal cord was converted to biotin-labeled cRNA,
which was hybridized to the Mouse WG-6 V2.0 BeadChip (Illumina). Gene
expression was analyzed according to BeadStudio Gene Expression Module
User Guide (Illumina).
Quantitative Real-Time PCR
Quantitative PCR was performed with Premix Ex Taq (Takara) using a 7500
real-time PCR system (Applied Biosystems), and the data were analyzed using
7500 System SDS Software 1.3.1.
Western Blot and Immunohistochemistry
Western blot and immunohistochemistry were performed using standard
methods. See Supplemental Information for details.
Microglial Culture
Mouse primary cultured microglia were prepared as described previously
(Tsuda et al., 2003, 2009).
Lentiviral Transduction
The lentiviral CS2-EF-MCS vector expressing mouse IRF8-GFP, IRF8(K79E)-
GFP (Tamura et al., 2000), or GFP alone were used. Viral particles were added
onto primary cultured microglia (1.2 3 105 cells/well). Total RNA in cultured
microglia 72 hr after the transduction were used for real-time PCR analysis.
For behavioral tests, the transduced microglia were washed, harvested, and
administering intrathecally to catheterized mice.
Intrathecal Administration
Intrathecal injection of IRF8 siRNA (20 pmol/5 ml) and cultured microglia (2 3
104 cells/5 ml) was followed by infusion of 3 ml of PBS. Fifteen minutes before
the injection of transduced microglia, cells were mixed with a reagent cocktail
(5 mL) containing an IL-1b neutralizing antibody (5 mg, R&D Systems) and the
CatS inhibitor Z-FL-COCHO (5 pmol, Calbiochem), or with a control vehicle.
Behavioral Studies
To assess mechanical sensitivity, calibrated von Frey filaments (0.02–2.0 g)
were applied to the plantar surfaces of the hindpaws of mice, and the 50%
PWT was determined. Methods for all other tests are described in the Supple-
mental Information.
Statistical Analysis
Statistical analyses were performed using the Student’s t test (Figures 4B,
4G–4I, and 4K), two-way ANOVA with post hoc Bonferroni test (Figures 1I,
1K, 4A, 4F, and 4J), one-way ANOVA with a post hoc Dunnett’s test (Figures
4A and 4D–4F), or Tukey’s test (Figures 2, 3A, 3B, 4D, and 4E) using GraphPad
Prism 4.03 software. Differences were considered significant at p < 0.05.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
four figures and can be found with this article online at doi:10.1016/j.celrep.
2012.02.014.Cell Reports 1, 334–340, April 19, 2012 ª2012 The Authors 339
LICENSING INFORMATION
This is an open-access article distributed under the terms of the Creative
Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported
License (CC-BY-NC-ND; http://creativecommons.org/licenses/by-nc-nd/3.0/
egalcode).
ACKNOWLEDGMENTS
This work was supported by grants from the JSPS through the NEXT Program
initiated by the CSTP (M.T.) and the MEXT of Japan (T.M., M.T., K.I.) and from
the Core-to-Core program of JSPS (K.I.). We thank Ms. Junko Kitano, Ms. Yu-
kari Hasegawa, Dr. Shigeo Hasegawa and the Research Support Center
(Graduate School of Medical Sciences, Kyushu University) for assisting with
experiments, and Dr. Hiroyuki Miyoshi (RIKEN BioResource Center) for
providing the lentiviral vector and its packaging plasmids. T.M. designed
and performed most of the experiments, analyzed the data, and wrote the
manuscript. M.T. conceived the study, supervised the overall project, per-
formed immunohistochemical experiments, and wrote the manuscript. R.Y.
assisted with the experiments. H.T.-S. optimized transduction of lentiviral
vectors into primary cultured microglia. K.O. and T.T. provided critical mate-
rials including Irf8–/– mice and advice on data interpretation. K.I. supervised
the overall project and wrote the manuscript.
Received: October 7, 2011
Revised: February 13, 2012
Accepted: February 29, 2012
Published online: April 5, 2012
REFERENCES
Barber, S.A., Fultz, M.J., Salkowski, C.A., and Vogel, S.N. (1995). Differential
expression of interferon regulatory factor 1 (IRF-1), IRF-2, and interferon
consensus sequence binding protein genes in lipopolysaccharide (LPS)-
responsive and LPS-hyporesponsive macrophages. Infect. Immun. 63,
601–608.
Burnstock, G. (2008). Purinergic signalling and disorders of the central nervous
system. Nat. Rev. Drug Discov. 7, 575–590.
Clark, A.K., Yip, P.K., Grist, J., Gentry, C., Staniland, A.A., Marchand, F.,
Dehvari, M., Wotherspoon, G., Winter, J., Ullah, J., et al. (2007). Inhibition of
spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl.
Acad. Sci. USA 104, 10655–10660.
Coull, J.A., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel,
C., Salter, M.W., and De Koninck, Y. (2005). BDNF from microglia causes
the shift in neuronal anion gradient underlying neuropathic pain. Nature 438,
1017–1021.
De Jager, P.L., Jia, X., Wang, J., de Bakker, P.I., Ottoboni, L., Aggarwal, N.T.,
Piccio, L., Raychaudhuri, S., Tran, D., Aubin, C., et al; International MS
Genetics Consortium. (2009). Meta-analysis of genome scans and replication
identify CD6, IRF8 and TNFRSF1A as newmultiple sclerosis susceptibility loci.
Nat. Genet. 41, 776–782.
Glass, C.K., Saijo, K., Winner, B., Marchetto, M.C., and Gage, F.H. (2010).
Mechanisms underlying inflammation in neurodegeneration. Cell 140,
918–934.
Hanisch, U.K., and Kettenmann, H. (2007). Microglia: active sensor and
versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10,
1387–1394.340 Cell Reports 1, 334–340, April 19, 2012 ª2012 The AuthorsHaynes, S.E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M.E., Gan, W.B.,
and Julius, D. (2006). The P2Y12 receptor regulates microglial activation by
extracellular nucleotides. Nat. Neurosci. 9, 1512–1519.
Holtschke, T., Lo¨hler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J.,
Knobeloch, K.P., Gabriele, L., Waring, J.F., et al. (1996). Immunodeficiency
and chronic myelogenous leukemia-like syndrome in mice with a targeted
mutation of the ICSBP gene. Cell 87, 307–317.
Honda, K., and Taniguchi, T. (2006). IRFs: master regulators of signalling
by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev.
Immunol. 6, 644–658.
Honda, S., Sasaki, Y., Ohsawa, K., Imai, Y., Nakamura, Y., Inoue, K., and
Kohsaka, S. (2001). Extracellular ATP or ADP induce chemotaxis of cultured
microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 21, 1975–1982.
Inoue, K., and Tsuda, M. (2009). Microglia and neuropathic pain. Glia 57, 1469–
1479.
Kawasaki, Y., Zhang, L., Cheng, J.K., and Ji, R.R. (2008). Cytokine
mechanisms of central sensitization: distinct and overlapping role of inter-
leukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating
synaptic and neuronal activity in the superficial spinal cord. J. Neurosci. 28,
5189–5194.
McMahon, S.B., and Malcangio, M. (2009). Current challenges in glia-pain
biology. Neuron 64, 46–54.
Perry, V.H., Nicoll, J.A., and Holmes, C. (2010). Microglia in neurodegenerative
disease. Nat. Rev. Neurol. 6, 193–201.
Politis, A.D., Ozato, K., Coligan, J.E., and Vogel, S.N. (1994). Regulation of
IFN-gamma-induced nuclear expression of IFN consensus sequence binding
protein in murine peritoneal macrophages. J. Immunol. 152, 2270–2278.
Ransohoff, R.M., and Cardona, A.E. (2010). The myeloid cells of the central
nervous system parenchyma. Nature 468, 253–262.
Rivest, S. (2009). Regulation of innate immune responses in the brain. Nat.
Rev. Immunol. 9, 429–439.
Sibinga, N.E., Feinberg, M.W., Yang, H., Werner, F., and Jain, M.K. (2002).
Macrophage-restricted and interferon gamma-inducible expression of the
allograft inflammatory factor-1 gene requires Pu.1. J. Biol. Chem. 277,
16202–16210.
Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T., and Ozato, K.
(2000). ICSBP directs bipotential myeloid progenitor cells to differentiate into
mature macrophages. Immunity 13, 155–165.
Tamura, T., Yanai, H., Savitsky, D., and Taniguchi, T. (2008). The IRF family
transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26,
535–584.
Tran, P.B., and Miller, R.J. (2003). Chemokine receptors: signposts to brain
development and disease. Nat. Rev. Neurosci. 4, 444–455.
Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S.,
Salter, M.W., and Inoue, K. (2003). P2X4 receptors induced in spinal microglia
gate tactile allodynia after nerve injury. Nature 424, 778–783.
Tsuda, M., Inoue, K., and Salter, M.W. (2005). Neuropathic pain and spinal
microglia: a big problem from molecules in ‘‘small’’ glia. Trends Neurosci.
28, 101–107.
Tsuda, M., Masuda, T., Kitano, J., Shimoyama, H., Tozaki-Saitoh, H., and
Inoue, K. (2009). IFN-gamma receptor signaling mediates spinal microglia
activation driving neuropathic pain. Proc. Natl. Acad. Sci. USA 106, 8032–
8037.
